The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival

Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, Elisabet Megías-Roda, Idoia Bolinaga-Ayala, Maria Viñas-Casas, Inés Domingo-Ortí, Héctor Pérez-Montoyo, Jose R. Bayascas, Eva Colas, Xavier Dolcet, Jose Miguel Lizcano^*

^*Corresponding author for this work

Ability Pharmaceuticals SL

Research output: Contribution to journal › Article › Research › peer-review

15 Citations (Scopus)

2 results

Filter

Finished
NEW ANTICANCER THERAPIES BASED ON MODULATION OF THE MAPK KINASE ERK5
Lizcano de Vega, J. M. (Principal Investigator), Dieguez Martinez, N. (Collaborator), Espinosa Gil, S. (Collaborator), Megias-Roda, E. (Collaborator), Yoldi Salinas, G. (Collaborator), Bolinaga Ayala, I. (Collaborator) & Viñas Casas, M. (Collaborator)
1/06/20 → 31/05/23
Project: Research Projects and Other Grants
Desarrollo de nuevas herramientas farmacológicas antitumorales que dirijan su acción al silenciamiento o a la inhibición de la map Kinasa ERK5
Lizcano de Vega, J. M. (Principal Investigator), Carbonell Teruel, E. (Collaborator) & Dieguez Martinez, N. (Collaborator)
Spanish Ministry of Economy and Competitiveness (MINECO)
1/01/16 → 31/12/19
Project: Research Projects and Other Grants

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival

Projects

Search results

NEW ANTICANCER THERAPIES BASED ON MODULATION OF THE MAPK KINASE ERK5

Desarrollo de nuevas herramientas farmacológicas antitumorales que dirijan su acción al silenciamiento o a la inhibición de la map Kinasa ERK5